What are the alternatives to Carafate (sucralfate) for treating stomach and duodenal ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Alternatives to Carafate (sucralfate) for treating stomach and duodenal ulcers include proton pump inhibitors (PPIs), H2 receptor antagonists, antacids, and prostaglandin analogs, with PPIs being the most effective first-line treatment option. When considering alternatives to Carafate, it's essential to prioritize treatments that reduce stomach acid production, protect the stomach lining, or eliminate H. pylori bacteria, which cause many ulcers. The most recent and highest quality study, 1, suggests that PPIs like omeprazole, esomeprazole, and pantoprazole are effective in treating peptic ulcer disease, with vonoprazan, a potassium-competitive acid blocker, being noninferior to lansoprazole for gastric ulcer healing. Key points to consider when choosing an alternative to Carafate include:

  • PPIs are typically first-line treatments, reducing stomach acid production for 4-8 weeks for duodenal ulcers and 8-12 weeks for gastric ulcers
  • H2 receptor antagonists like famotidine and ranitidine also reduce acid production but are less potent than PPIs
  • Antacids containing aluminum hydroxide, magnesium hydroxide, or calcium carbonate can provide quick symptom relief when taken as needed
  • For ulcers caused by H. pylori infection, triple therapy combining a PPI with two antibiotics is essential for eradication
  • Prostaglandin analogs like misoprostol help protect the stomach lining but are less commonly used due to side effects, as noted in 1. Overall, the choice of alternative to Carafate should be based on the individual patient's needs and medical history, with PPIs being a preferred first-line treatment option due to their efficacy and safety profile, as supported by 1.

From the FDA Drug Label

In adults Lansoprazole delayed-release capsules used for: for 4 weeks for the healing and symptom relief of duodenal ulcers. In children 1 to 11 years of age, lansoprazole are used for: up to 12 weeks to treat heartburn and other symptoms that can happen with GERD. Ranitidine has been found to be effective as maintenance therapy for patients following healing of acute duodenal ulcers In a multicenter, double-blind, controlled, US study of endoscopically diagnosed gastric ulcers, earlier healing was seen in the patients treated with ranitidine

Alternatives to Carafate (sucralfate) for treating stomach and duodenal ulcers include:

  • Lansoprazole: a proton pump inhibitor (PPI) that reduces the amount of acid in the stomach, used for healing and symptom relief of duodenal ulcers and stomach ulcers 2
  • Ranitidine: an H2-antagonist that inhibits gastric acid secretion, used for healing and maintenance therapy of duodenal ulcers and gastric ulcers 3

From the Research

Carafate Alternatives

Alternatives to Carafate (sucralfate) for treating stomach and duodenal ulcers include:

  • Proton pump inhibitors (PPIs) such as omeprazole, lansoprazole, pantoprazole, and rabeprazole 4, 5, 6, 7, 8
  • Histamine H2 receptor antagonists, although PPIs have been shown to be more effective in healing duodenal and gastric ulcers 4, 5, 7, 8
  • Misoprostol, which is effective in preventing non-steroidal anti-inflammatory drug-induced gastroduodenal lesions, but may have more side effects than PPIs 6

Proton Pump Inhibitors

PPIs are the most potent gastric acid-suppressing agents in clinical use and have been shown to be effective in:

  • Healing duodenal and gastric ulcers 4, 5, 6, 7, 8
  • Eradicating Helicobacter pylori infection when combined with antibiotics 4, 5, 8
  • Reducing the risk of gastric and duodenal ulcers in patients taking non-steroidal anti-inflammatory drugs 6
  • Treating Zollinger-Ellison syndrome and other acid-related disorders 4, 5, 7, 8

Comparison of PPIs

Different PPIs have been compared in clinical trials, with no conclusive evidence to support the use of one PPI over another for duodenal or gastric ulcer healing 4, 5, 8. However, lansoprazole and omeprazole have been shown to be more effective than ranitidine and misoprostol in some studies 5, 6, 8.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lansoprazole and omeprazole in the treatment of acid peptic disorders.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996

Research

Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001

Research

Lansoprazole: a proton pump inhibitor.

The Annals of pharmacotherapy, 1996

Research

Lansoprazole: a comprehensive review.

Pharmacotherapy, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.